Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA

By sjmartinez • March 3, 2025

Xu X, Wang X, Liao YP, Luo L, Nel AE. Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA. ACS Nano. 2025 Mar 2. doi: 10.1021/acsnano.4c14102. Epub ahead of print. PMID: 40025875.

Tags: cancer vaccine, lipid nanoparticles, liver metastasis, mRNA delivery, Nano Medicine, pancreatic cancer, Post Doc, Publications

33 Unresolved Questions in Nanoscience and Nanotechnology

Mirkin CA, Petrosko SH, Artzi N, Aydin K, Biaggne A, Brinker CJ, Bujold KE, Cao YC, Chan RR, Chen C, Chen PC, Chen X, Chevalier[...]

KRAS mRNA Spleen-Targeting Lipid Nanoparticles Synergize with Irinotecan Silicasomes to Robustly Augment the Cancer Immunity Cycle in Pancreatic Cancer

Luo L, Wang X, Liao YP, Nel AE. KRAS mRNA Spleen-Targeting Lipid Nanoparticles Synergize with Irinotecan Silicasomes to Robustly Augment the Cancer Immunity Cycle in[...]

Correction: Reduction of pulmonary toxicity of metal oxide nanoparticles by phosphonate-based surface passivation

Cai X, Lee A, Ji Z, Huang C, Chang CH, Wang X, Liao YP, Xia T, Li R. Correction: Reduction of pulmonary toxicity of metal[...]